InvestorsHub Logo
Followers 23
Posts 2120
Boards Moderated 0
Alias Born 06/21/2015

Re: None

Friday, 07/31/2015 4:25:10 PM

Friday, July 31, 2015 4:25:10 PM

Post# of 461229
FWIW
Can we expect any Phase 2 updates before the end of the year?

From IR

PART A of the Phase 2a trial is expected to be completed by the end of the year. Anavex is seeking to expand PART B, the extension period, from 26 to 52 weeks at the request of study participants. As of this time, the company has not specified a timeframe to report additional results of the Phase 2a trial.

Please do not hesitate to contact our office if we can be of further assistance.

On behalf of Anavex Life Sciences Corp.,

Christine Payne
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News